title: Endoscopic retrograde cholangiopancreatography for non-gastroenterologists: what you need to know.
abstract: Endoscopic retrograde cholangiopancreatography (ERCP) represents the most powerful and widely employed platform for pancreaticobiliary interventions. Endoscopic retrograde cholangiopancreatography allows diagnosis and treatment of a broad spectrum of diseases of the pancreaticobiliary tree that are both benign and malignant in nature. Endoscopic retrograde cholangiopancreatography continues to evolve rapidly, and non-gastroenterologists need to understand the indications, contraindications, limitations, and role of ERCP to effectively manage and coordinate the care of patients with known or suspected pancreaticobiliary disease. This article will review the role of ERCP in detail to further an understanding of the procedure as a whole and to assess when referral of a patient for an ERCP or other related test is indicated.
authors.affiliation: Division of Gastroenterology and Hepatology, University of Utah School of Medicine, Huntsman Cancer Center, Salt Lake City, UT 84312, USA.
authors.forename: Geetha
authors.initials: G
authors.lastname: Nallamothu
authors.forename: Kristen
authors.initials: K
authors.lastname: Hilden
authors.forename: Douglas G
authors.initials: DG
authors.lastname: Adler
mesh_terms: D001649:Bile Duct Diseases / Q000175:diagnosis* / Q000628:therapy*; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D010182:Pancreatic Diseases / Q000175:diagnosis* / Q000628:therapy*